Literature DB >> 24012873

Binding and discerning interactions of PTP1B allosteric inhibitors: novel insights from molecular dynamics simulations.

Ranajit Nivrutti Shinde1, M Elizabeth Sobhia.   

Abstract

The α7 helix is either disordered or missing in the three co-crystal structures of allosteric inhibitors with protein tyrosine phosphatase 1B (PTP1B). It was modeled in each complex using the open form of PTP1B structure and studied using molecular dynamics (MD) simulations for 25 ns. B-factor analysis of the residues sheds light on its disordered nature in the co-crystal structures. Further, the ability of inhibitors to act as allosteric inhibitor was studied and established using novel hydrogen bond criteria. The MD simulations were utilized to determine the relative importance of electrostatic and hydrophobic component in to the binding of inhibitors. It was revealed that the hydrophobic interactions predominantly drive the molecular recognition of these inhibitors. Per residue energy decomposition analysis attributed dissimilar affinities of three inhibitors to the several hydrogen bonds and non-bonded interactions. Among the secondary structure elements that surround the allosteric site, helices α6, α7 and loop α6-α7 were notorious in providing variable affinities to the inhibitors. A novel hydrophobic pocket lined by the α7 helix residues Val287, Asn289 and Trp291 was identified in the allosteric site. This study provides useful insights for the rational design of high affinity PTP1B allosteric inhibitors.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allosteric inhibition; B-factor; Binding free energy; Hydrogen bond; Molecular modeling; Per-residue energy decomposition

Mesh:

Substances:

Year:  2013        PMID: 24012873     DOI: 10.1016/j.jmgm.2013.08.001

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  7 in total

1.  Conformational Rigidity and Protein Dynamics at Distinct Timescales Regulate PTP1B Activity and Allostery.

Authors:  Meng S Choy; Yang Li; Luciana E S F Machado; Micha B A Kunze; Christopher R Connors; Xingyu Wei; Kresten Lindorff-Larsen; Rebecca Page; Wolfgang Peti
Journal:  Mol Cell       Date:  2017-02-16       Impact factor: 17.970

2.  4-((1E)-2-(5-(4-hydroxy-3-methoxystyryl-)-1-phenyl-1H-pyrazoyl-3-yl) vinyl)-2-methoxy-phenol) (CNB-001) Does Not Regulate Human Recombinant Protein-Tyrosine Phosphatase1B (PTP1B) Activity in vitro.

Authors:  Paul A Lapchak; Jacqueline A Lara; Paul D Boitano
Journal:  J Neurol Neurophysiol       Date:  2014-09-29

3.  Selective binding modes and allosteric inhibitory effects of lupane triterpenes on protein tyrosine phosphatase 1B.

Authors:  Tiantian Jin; Haibo Yu; Xu-Feng Huang
Journal:  Sci Rep       Date:  2016-02-11       Impact factor: 4.379

4.  Screening and identification of potential PTP1B allosteric inhibitors using in silico and in vitro approaches.

Authors:  Ranajit Nivrutti Shinde; G Siva Kumar; Shahbaz Eqbal; M Elizabeth Sobhia
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

5.  In Silico Screening and Binding Characterization of Small Molecules toward a G-Quadruplex Structure Formed in the Promoter Region of c-MYC Oncogene.

Authors:  Jyotsna Bhat; Soma Mondal; Pallabi Sengupta; Subhrangsu Chatterjee
Journal:  ACS Omega       Date:  2017-08-09

6.  Novel Mixed-Type Inhibitors of Protein Tyrosine Phosphatase 1B. Kinetic and Computational Studies.

Authors:  Marie Jazmín Sarabia-Sánchez; Pedro Josué Trejo-Soto; José Miguel Velázquez-López; Carlos Carvente-García; Rafael Castillo; Alicia Hernández-Campos; Claudia Avitia-Domínguez; Daniel Enríquez-Mendiola; Erick Sierra-Campos; Mónica Valdez-Solana; José Manuel Salas-Pacheco; Alfredo Téllez-Valencia
Journal:  Molecules       Date:  2017-12-20       Impact factor: 4.411

7.  A Computer-Driven Scaffold-Hopping Approach Generating New PTP1B Inhibitors from the Pyrrolo[1,2-a]quinoxaline Core.

Authors:  Javier García-Marín; Mercedes Griera; Ramón Alajarín; Manuel Rodríguez-Puyol; Diego Rodríguez-Puyol; Juan J Vaquero
Journal:  ChemMedChem       Date:  2021-07-19       Impact factor: 3.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.